| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Review |
From the Department of Laboratory Medicine and Pathology, Mayo Foundation and Mayo Clinic, Rochester, Minnesota
p27kip1 (p27) is a member of the universal cyclin-dependent kinase inhibitor (CDKI) family. p27 expression is regulated by cell contact inhibition and by specific growth factors, such as transforming growth factor (TGF)-ß. Since the cloning of the p27 gene in 1994, a host of other functions have been associated with this cell cycle protein. In addition to its role as a CDKI, p27 is a putative tumor suppressor gene, regulator of drug resistance in solid tumors, and promoter of apoptosis; acts as a safeguard against inflammatory injury; and has a role in cell differentiation. The level of p27 protein expression decreases during tumor development and progression in some epithelial, lymphoid, and endocrine tissues. This decrease occurs mainly at the post-translational level with protein degradation by the ubiquitin-proteasome pathway. A large number of studies have characterized p27 as an independent prognostic factor in various human cancers, including breast, colon, and prostate adenocarcinomas. Here we review the role of p27 in the regulation of the cell cycle and other cell functions and as a diagnostic and prognostic marker in human neoplasms. We also review studies indicating the increasingly important roles of p27, other CDKIs, and cyclins in endocrine cell hyperplasia and tumor development.
This article has been cited by other articles:
 |
|
 |
|
  K. Yoshinaga, K. Yamashita, K. Mimori, F. Tanaka, H. Inoue, and M. Mori Activin A Causes Cancer Cell Aggressiveness in Esophageal Squamous Cell Carcinoma Cells Ann. Surg. Oncol., January 1, 2008; 15(1): 96 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Galardi, N. Mercatelli, E. Giorda, S. Massalini, G. V. Frajese, S. A. Ciafre, and M. G. Farace miR-221 and miR-222 Expression Affects the Proliferation Potential of Human Prostate Carcinoma Cell Lines by Targeting p27Kip1 J. Biol. Chem., August 10, 2007; 282(32): 23716 - 23724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Muzumdar, L. Luo, and H. Zong From the Cover: Modeling sporadic loss of heterozygosity in mice by using mosaic analysis with double markers (MADM) PNAS, March 13, 2007; 104(11): 4495 - 4500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Massarweh, C. K. Osborne, S. Jiang, A. E. Wakeling, M. Rimawi, S. K. Mohsin, S. Hilsenbeck, and R. Schiff Mechanisms of Tumor Regression and Resistance to Estrogen Deprivation and Fulvestrant in a Model of Estrogen Receptor-Positive, HER-2/neu-Positive Breast Cancer Cancer Res., August 15, 2006; 66(16): 8266 - 8273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Codony-Servat, M. A. Tapia, M. Bosch, C. Oliva, J. Domingo-Domenech, B. Mellado, M. Rolfe, J. S. Ross, P. Gascon, A. Rovira, et al. Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells. Mol. Cancer Ther., March 1, 2006; 5(3): 665 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. S. Lossos and D. Morgensztern Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma J. Clin. Oncol., February 20, 2006; 24(6): 995 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Dutu, S. Michiels, P. Fouret, F. Penault-Llorca, P. Validire, S. Benhamou, E. Taranchon, L. Morat, D. Grunenwald, T. Le Chevalier, et al. Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers Ann. Onc., December 1, 2005; 16(12): 1906 - 1914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yang, L. Bancroft, J. Liang, M. Zhuang, and L. H. Augenlicht p27kip1 in Intestinal Tumorigenesis and Chemoprevention in the Mouse Cancer Res., October 15, 2005; 65(20): 9363 - 9368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Belanger, P. Beaulieu, C. Moreau, D. Labuda, T. J. Hudson, and D. Sinnett Functional promoter SNPs in cell cycle checkpoint genes Hum. Mol. Genet., September 15, 2005; 14(18): 2641 - 2648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Chesnokova, K. Kovacs, A.-V. Castro, S. Zonis, and S. Melmed Pituitary Hypoplasia in Pttg-/- Mice Is Protective for Rb+/- Pituitary Tumorigenesis Mol. Endocrinol., September 1, 2005; 19(9): 2371 - 2379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, Z. Liu, E. M. Sturgis, Q. Shi, R. M. Chamberlain, M. R. Spitz, and Q. Wei Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck Carcinogenesis, September 1, 2005; 26(9): 1596 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Jeon, K.-N. Lee, C. Y. Hwang, K.-S. Kwon, K.-H. You, and I. Choi Tumor Suppressor VDUP1 Increases p27kip1 Stability by Inhibiting JAB1 Cancer Res., June 1, 2005; 65(11): 4485 - 4489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Carloni, F. Vizzutti, and P. Pantaleo Farnesyltransferase Inhibitor, ABT-100, Is a Potent Liver Cancer Chemopreventive Agent Clin. Cancer Res., June 1, 2005; 11(11): 4266 - 4274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, R. T. Poon, Q. Li, T. W. Kok, C. Lau, and S. T. Fan Both Antiangiogenesis- and Angiogenesis-Independent Effects Are Responsible for Hepatocellular Carcinoma Growth Arrest by Tyrosine Kinase Inhibitor PTK787/ZK222584 Cancer Res., May 1, 2005; 65(9): 3691 - 3699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cho, J. H. Kim, S. H. Back, and S. K. Jang Polypyrimidine Tract-Binding Protein Enhances the Internal Ribosomal Entry Site-Dependent Translation of p27Kip1 mRNA and Modulates Transition from G1 to S Phase Mol. Cell. Biol., February 15, 2005; 25(4): 1283 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Brzezinski, A. Migodzinski, A. Toczek, J. Tazbir, and M. Dedecjus Patterns of Cyclin E, Retinoblastoma Protein, and p21Cip1/WAF1 Immunostaining in the Oncogenesis of Papillary Thyroid Carcinoma Clin. Cancer Res., February 1, 2005; 11(3): 1037 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Rosen, G. Yang, K. Q. Cai, R. C. Bast Jr., D. M. Gershenson, E. G. Silva, and J. Liu Subcellular Localization of p27kip1 Expression Predicts Poor Prognosis in Human Ovarian Cancer Clin. Cancer Res., January 15, 2005; 11(2): 632 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Waldman Markers of Cell Cycle-Mediated Drug Resistance And Prognosis Of Patients Receiving Preoperative Combined Modality Therapy For Rectal Cancer Ann. Surg. Oncol., November 1, 2004; 11(11): 949 - 950. [Full Text] [PDF]
|
|
|
|
|
|
A. Osoegawa, I. Yoshino, S. Tanaka, K. Sugio, T. Kameyama, M. Yamaguchi, and Y. Maehara Regulation of p27 by S-Phase Kinase-Associated Protein 2 Is Associated With Aggressiveness in Non-Small-Cell Lung Cancer J. Clin. Oncol., October 15, 2004; 22(20): 4165 - 4173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. N. Papandreou and C. J. Logothetis Bortezomib as a Potential Treatment for Prostate Cancer Cancer Res., August 1, 2004; 64(15): 5036 - 5043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Adhami, M. H. Aziz, S. R. Reagan-Shaw, M. Nihal, H. Mukhtar, and N. Ahmad Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery Mol. Cancer Ther., August 1, 2004; 3(8): 933 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, E. M. Sturgis, L.-E. Wang, R. M. Chamberlain, M. R. Spitz, A. K. El-Naggar, W. K. Hong, and Q. Wei Association between the V109G Polymorphism of the p27 Gene and the Risk and Progression of Oral Squamous Cell Carcinoma Clin. Cancer Res., June 15, 2004; 10(12): 3996 - 4002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zisis, D. Rontogianni, K. Stefanaki, and I. Bellenis Expression of cyclins D1, D3 and p27 in thymic epithelial tumors Interactive CardioVascular and Thoracic Surgery, June 1, 2004; 3(2): 245 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wu, T. Hayashi, and M. Inoue Immunohistochemical Expression of p27 and p21 in Canine Cutaneous Mast Cell Tumors and Histiocytomas Vet. Pathol., May 1, 2004; 41(3): 296 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. King and P. D. Lampe Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation Carcinogenesis, May 1, 2004; 25(5): 669 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Gary, R. Azuero, G. S. Mohanty, W. C. Bell, I.-E. A. Eltoum, and S. A. Abdulkadir Interaction of Nkx3.1 and p27kip1 in Prostate Tumor Initiation Am. J. Pathol., May 1, 2004; 164(5): 1607 - 1614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Barton, H. A. Runnels, T. D. Schell, Y. Cho, R. Gibbons, S. S. Tevethia, G. S. Deepe Jr., and J. J. Monaco Immune Defects in 28-kDa Proteasome Activator {gamma}-Deficient Mice J. Immunol., March 15, 2004; 172(6): 3948 - 3954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Gadhoum, M.-P. Leibovitch, J. Qi, D. Dumenil, L. Durand, S. Leibovitch, and F. Smadja-Joffe CD44: a new means to inhibit acute myeloid leukemia cell proliferation via p27Kip1 Blood, February 1, 2004; 103(3): 1059 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Xing Cui, Song Li, A. Shraim, Y. Kobayashi, T. Hayakawa, S. Kanno, M. Yamamoto, and S. Hirano Subchronic Exposure to Arsenic Through Drinking Water Alters Expression of Cancer-Related Genes in Rat Liver Toxicol Pathol, January 1, 2004; 32(1): 64 - 72. [Abstract] [PDF]
|
|
|
|
 |
|
 A A Khan, P D Abel, K S Chaudhary, Z Gulzar, G W H Stamp, and E-N Lalani Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder Mol. Pathol., December 1, 2003; 56(6): 353 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tsutsumi, T. Yanagawa, T. Shimura, T. Fukumori, V. Hogan, H. Kuwano, and A. Raz Regulation of Cell Proliferation by Autocrine Motility Factor/Phosphoglucose Isomerase Signaling J. Biol. Chem., August 22, 2003; 278(34): 32165 - 32172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Troncone, A Iaccarino, A Caleo, D Bifano, G Pettinato, and L Palombini p27Kip1 protein expression in Hashimoto's thyroiditis J. Clin. Pathol., August 1, 2003; 56(8): 587 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Matsuda, T. Ichida, T. Genda, S. Yamagiwa, Y. Aoyagi, and H. Asakura Loss of p16 Contributes to p27 Sequestration by Cyclin D1-Cyclin-dependent Kinase 4 Complexes and Poor Prognosis in Hepatocellular Carcinoma Clin. Cancer Res., August 1, 2003; 9(9): 3389 - 3396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tadlock, Y. Yamagiwa, J. Hawker, C. Marienfeld, and T. Patel Transforming growth factor-{beta} inhibition of proteasomal activity: a potential mechanism of growth arrest Am J Physiol Cell Physiol, August 1, 2003; 285(2): C277 - C285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Moeller, E. D. Head, and R. J. Sheaff p27Kip1 Inhibition of GRB2-SOS Formation Can Regulate Ras Activation Mol. Cell. Biol., June 1, 2003; 23(11): 3735 - 3752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Riss, L. Jin, X. Qian, J. Bayliss, B. W. Scheithauer, W. F. Young Jr., S. Vidal, K. Kovacs, A. Raz, and R. V. Lloyd Differential Expression of Galectin-3 in Pituitary Tumors Cancer Res., May 1, 2003; 63(9): 2251 - 2255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.-H. Shim, L. Johnson, H.-L. Noh, Y.-J. Kim, H. Sun, C. Zeiss, and H. Zhang Expression of the F-Box Protein SKP2 Induces Hyperplasia, Dysplasia, and Low-Grade Carcinoma in the Mouse Prostate Cancer Res., April 1, 2003; 63(7): 1583 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Fouty and D. M. Rodman Mevastatin Can Cause G1 Arrest and Induce Apoptosis in Pulmonary Artery Smooth Muscle Cells Through a p27Kip1-Independent Pathway Circ. Res., March 21, 2003; 92(5): 501 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Oliveira, S. H. Okuno, A. G. Nascimento, and R. V. Lloyd Skp2 Protein Expression in Soft Tissue Sarcomas J. Clin. Oncol., February 15, 2003; 21(4): 722 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sanchez-Beato, A. Sanchez-Aguilera, and M. A. Piris Cell cycle deregulation in B-cell lymphomas Blood, February 15, 2003; 101(4): 1220 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schnittger, C. Weinl, D. Bouyer, U. Schobinger, and M. Hulskamp Misexpression of the Cyclin-Dependent Kinase Inhibitor ICK1/KRP1 in Single-Celled Arabidopsis Trichomes Reduces Endoreduplication and Cell Size and Induces Cell Death PLANT CELL, February 1, 2003; 15(2): 303 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mazzocca, S. Giusti, A. D. Hamilton, S. M. Sebti, P. Pantaleo, and V. Carloni Growth Inhibition by the Farnesyltransferase Inhibitor FTI-277 Involves Bcl-2 Expression and Defective Association with Raf-1 in Liver Cancer Cell Lines Mol. Pharmacol., January 1, 2003; 63(1): 159 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hoos, A. Nissan, A. Stojadinovic, J. Shia, C. V. Hedvat, D. H. Y. Leung, P. B. Paty, D. Klimstra, C. Cordon-Cardo, and W. D. Wong Tissue Microarray Molecular Profiling of Early, Node-negative Adenocarcinoma of the Rectum: A Comprehensive Analysis Clin. Cancer Res., December 1, 2002; 8(12): 3841 - 3849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tao, P. M. Kramer, W. Wang, S. Yang, R. A. Lubet, V. E. Steele, and M. A. Pereira Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents Carcinogenesis, September 1, 2002; 23(9): 1447 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Hwang, C. P. Martins, Y. Bronkhorst, E. Randel, A. Berns, M. Fero, and B. E. Clurman Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis PNAS, August 20, 2002; 99(17): 11293 - 11298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Pereira, Y. Li, W. T. Gunning, P. M. Kramer, F. Al-Yaqoub, R. A. Lubet, V. E. Steele, E. Szabo, and L. Tao Prevention of mouse lung tumors by budesonide and its modulation of biomarkers Carcinogenesis, July 1, 2002; 23(7): 1185 - 1192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vanzulli, A. Efeyan, F. Benavides, L. A. Helguero, G. Peters, J. Shen, C. J. Conti, C. Lanari, and A. Molinolo p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas Carcinogenesis, May 1, 2002; 23(5): 749 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. P. L. Kops, R. H. Medema, J. Glassford, M. A. G. Essers, P. F. Dijkers, P. J. Coffer, E. W.-F. Lam, and B. M. T. Burgering Control of Cell Cycle Exit and Entry by Protein Kinase B-Regulated Forkhead Transcription Factors Mol. Cell. Biol., April 1, 2002; 22(7): 2025 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Lloyd, K. H. Ruebel, S. Zhang, and L. Jin Pituitary Hyperplasia in Glycoprotein Hormone Alpha Subunit-, p18INK4C-, and p27kip-1-Null Mice : Analysis of Proteins Influencing p27kip-1 Ubiquitin Degradation Am. J. Pathol., March 1, 2002; 160(3): 1171 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Utsunomiya, H. Inoue, K.-I. Taguchi, M. Shimada, K. Sugimachi, and M. Mori G Protein {gamma}7 Expression as a New Clinicopathological Marker in Patients With Intrahepatic Cholangiocarcinoma Arch Surg, February 1, 2002; 137(2): 181 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Fouty, B. Grimison, K. A. Fagan, T. D. Le Cras, J. W. Harral, M. Hoedt-Miller, R. A. Sclafani, and D. M. Rodman p27Kip1 Is Important in Modulating Pulmonary Artery Smooth Muscle Cell Proliferation Am. J. Respir. Cell Mol. Biol., November 1, 2001; 25(5): 652 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Madewell, S. Griffey, J. Walls, and R. Gandour-Edwards Reduced Expression of Cyclin-dependent Kinase Inhibitor p27Kip1 in Feline Lymphoma Vet. Pathol., November 1, 2001; 38(6): 698 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Miskimins, G. Wang, M. Hawkinson, and R. Miskimins Control of Cyclin-Dependent Kinase Inhibitor p27 Expression by Cap-Independent Translation Mol. Cell. Biol., August 1, 2001; 21(15): 4960 - 4967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.J. Messner, P. Ao, A.B. Jagdale, and A.L. Boynton Abbreviated cell cycle progression induced by the serine/threonine protein phosphatase inhibitor okadaic acid at concentrations that promote neoplastic transformation Carcinogenesis, August 1, 2001; 22(8): 1163 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Park, J. Y. Seol, T.-Y. Kim, C.-G. Yoo, Y. W. Kim, S. K. Han, Y.-S. Shim, and C.-T. Lee An Adenovirus Expressing Mutant p27 Showed More Potent Antitumor Effects Than Adenovirus-p27 Wild Type Cancer Res., August 1, 2001; 61(16): 6163 - 6169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. Said, R. C. B. Moraes, U. Singh, F. S. Kittrell, and D. Medina Cyclin-dependent Kinase (cdk) Inhibitors/cdk4/cdk2 Complexes in Early Stages of Mouse Mammary Preneoplasia Cell Growth Differ., June 1, 2001; 12(6): 285 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Dong, E. Loukinova, Z. Chen, L. Gangi, T. I. Chanturita, E. T. Liu, and C. Van Waes Molecular Profiling of Transformed and Metastatic Murine Squamous Carcinoma Cells by Differential Display and cDNA Microarray Reveals Altered Expression of Multiple Genes Related to Growth, Apoptosis, Angiogenesis, and the NF-{{kappa}}B Signal Pathway Cancer Res., June 1, 2001; 61(12): 4797 - 4808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Velasco-Sampayo and S. Alemany p27kif Protein Levels and E2F Activity Are Targets of Cot Kinase During G1 Phase Progression in T Cells J. Immunol., May 15, 2001; 166(10): 6084 - 6090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Quaroni, J. Q. Tian, P. Seth, and C. Ap Rhys p27Kip1 is an inducer of intestinal epithelial cell differentiation Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1045 - C1057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Hommura, H. Dosaka-Akita, T. Mishina, M. Nishi, T. Kojima, H. Hiroumi, S. Ogura, M. Shimizu, H. Katoh, and Y. Kawakami Prognostic Significance of p27KIP1 Protein and Ki-67 Growth Fraction in Non-small Cell Lung Cancers Clin. Cancer Res., October 1, 2000; 6(10): 4073 - 4081. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Jiang, R. C. H. Zhao, and C. M. Verfaillie Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34+ cell proliferation: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27Kip, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity PNAS, September 5, 2000; (2000) 190104497. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Shirin, E. M. Sordillo, T. K. Kolevska, H. Hibshoosh, Y. Kawabata, S. H. Oh, J. F. Kuebler, T. Delohery, C. M. We |
